Potential of antiviral therapy and prophylaxis for controlling RNA viral infections of livestock - PubMed
Review
Potential of antiviral therapy and prophylaxis for controlling RNA viral infections of livestock
Nesya Goris et al. Antiviral Res. 2008 Apr.
Abstract
With intensification of trade, livestock are increasingly exposed to severe animal diseases caused by a range of RNA viruses. Recent prime examples include outbreaks of foot-and-mouth disease (FMD), peste des petits ruminants, Rift Valley fever and bluetongue. To minimise their impact, controlling the spread of virus is of utmost importance. Good quality, reliable vaccines exist for some, although not all, of these diseases, but suffer from a set of drawbacks, not the least of which being the time needed to trigger the immune response (i.e. "immunity-gap"). Effective, rapid control tools are, therefore, urgently needed and antiviral compounds could serve this purpose. Although limited in vitro and in vivo research has been performed, encouraging results for FMD suggest that livestock could be protected against infection within 24h following antiviral treatment and up to 12h post-infection. Such prophylactic/therapeutic antiviral drugs could complement emergency vaccination in a previously disease-free setting or be applied to treat valuable zoological collections and breeding stocks in endemic and previously disease-free regions alike. This paper will primarily focus on the effects of FMD on livestock and other sectors, and on appropriate control tools. The outlined principles can be extrapolated to other RNA viral diseases.
Similar articles
-
Highly pathogenic RNA viral infections: challenges for antiviral research.
Bray M. Bray M. Antiviral Res. 2008 Apr;78(1):1-8. doi: 10.1016/j.antiviral.2007.12.007. Epub 2008 Jan 10. Antiviral Res. 2008. PMID: 18243346 Review.
-
Goris N, De Palma A, Toussaint JF, Musch I, Neyts J, De Clercq K. Goris N, et al. Antiviral Res. 2007 Mar;73(3):161-8. doi: 10.1016/j.antiviral.2006.09.007. Epub 2006 Oct 10. Antiviral Res. 2007. PMID: 17055073
-
Kim SM, Lee KN, Park JY, Ko YJ, Joo YS, Kim HS, Park JH. Kim SM, et al. Antiviral Res. 2008 Nov;80(2):178-84. doi: 10.1016/j.antiviral.2008.06.001. Epub 2008 Jul 2. Antiviral Res. 2008. PMID: 18601955
-
Jamal SM, Bouma A, van den Broek J, Stegeman A, Chénard G, Dekker A. Jamal SM, et al. Vaccine. 2008 Nov 25;26(50):6317-21. doi: 10.1016/j.vaccine.2008.09.021. Epub 2008 Sep 24. Vaccine. 2008. PMID: 18822336
Cited by
-
In vitro antiviral efficacy of pleconaril and ribavirin on foot-and-mouth disease virus replication.
Soumajit S, Tamil Selvan RP, Bhanuprakash V. Soumajit S, et al. Virusdisease. 2019 Dec;30(4):562-570. doi: 10.1007/s13337-019-00559-w. Epub 2019 Dec 5. Virusdisease. 2019. PMID: 31890754 Free PMC article.
-
Host-Directed Antiviral Therapy.
Kumar N, Sharma S, Kumar R, Tripathi BN, Barua S, Ly H, Rouse BT. Kumar N, et al. Clin Microbiol Rev. 2020 May 13;33(3):e00168-19. doi: 10.1128/CMR.00168-19. Print 2020 Jun 17. Clin Microbiol Rev. 2020. PMID: 32404434 Free PMC article. Review.
-
Peste des petits ruminants virus infection of small ruminants: a comprehensive review.
Kumar N, Maherchandani S, Kashyap SK, Singh SV, Sharma S, Chaubey KK, Ly H. Kumar N, et al. Viruses. 2014 Jun 6;6(6):2287-327. doi: 10.3390/v6062287. Viruses. 2014. PMID: 24915458 Free PMC article. Review.
-
Potent small molecule inhibitors against the 3C protease of foot-and-mouth disease virus.
Kim Y, Pool E, Kim E, Dampalla CS, Nguyen HN, Johnson DK, Lovell S, Groutas WC, Chang K-O. Kim Y, et al. Microbiol Spectr. 2024 Apr 2;12(4):e0337223. doi: 10.1128/spectrum.03372-23. Epub 2024 Mar 11. Microbiol Spectr. 2024. PMID: 38466127 Free PMC article.
-
Goulding LV, Kiss E, Vrancken R, Goris N, Luo M, Groaz E, Herdewijn P, Dixon L. Goulding LV, et al. mSphere. 2022 Dec 21;7(6):e0037822. doi: 10.1128/msphere.00378-22. Epub 2022 Nov 1. mSphere. 2022. PMID: 36317894 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous